Forecast & Rating4 analysts currently cover Apnimed, of which 4 give a positive rating. The average price target is $50.33, about 138.7% upside from the current price of $21.09. Coverage is limited, so the data is for reference only. Data as of Sep 11, 2026; this does not constitute investment advice.
Sep 11, 2026Price forecast
$50.33138.66%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 25, 2026
Forecast met0.0%
Stock price$21.09
Avg. target$50.3
High target$60
Low target$41
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.